📄 Article
✓ Link checked
India
Free
Intermediate
The January 2025 report of the one-year extension for drug makers under Rs 250 crore turnover, and the conditions attached: a gap analysis and a compliance plan filed with the regulator.
Health Ministry grants additional one year relief to MSME pharma companies to upgrade facilities under Schedule M
From medicaldialogues.in by Medical Dialogues News
- Know the history: MSMEs had until 31 December 2025 and conditions to meet.
- Do a gap analysis against revised Schedule M before buying a plant.
- Ask any contract manufacturer for its compliance status.
